Free Trial

GT Biopharma (GTBP) Stock Chart & Stock Price History

GT Biopharma logo
$2.31 -0.08 (-3.35%)
As of 04:00 PM Eastern

GT Biopharma Stock Price Performance

5 Day
Performance
+0.86%
1 Month
Performance
+34.67%
3 Month
Performance
-2.89%
6 Month
Performance
-14.55%
Year-To-Date
Performance
-22.95%
1 Year
Performance
-66.67%
Receive GTBP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for GT Biopharma and its competitors with MarketBeat's FREE daily newsletter.

GTBP Stock Chart for Tuesday, January, 21, 2025

GT Biopharma Stock Price History

DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization
01/20/2025$2.39$2.39$2.51$2.3272,495 shs$5.33 million
01/17/2025$2.33$2.39
+2.58%
$2.51$2.3272,495 shs$5.33 million
01/16/2025$2.35$2.33
-0.85%
$2.50$2.3285,858 shs$5.20 million
01/15/2025$2.52$2.35
-6.75%
$2.63$2.3594,637 shs$5.25 million
01/14/2025$2.39$2.52
+5.44%
$2.62$2.24114,696 shs$5.63 million
01/13/2025$2.65$2.39
-9.81%
$2.58$1.993.86 million shs$5.34 million
01/10/2025$2.55$2.65
+3.92%
$2.66$2.5135,420 shs$5.92 million
01/09/2025$2.55$2.55$2.75$2.5524,522 shs$5.70 million
01/08/2025$2.87$2.55
-11.15%
$2.75$2.5524,522 shs$5.70 million
01/07/2025$2.99$2.87
-4.01%
$3.05$2.84101,712 shs$6.41 million
01/06/2025$3.00$2.99
-0.33%
$3.10$2.9586,414 shs$6.68 million
01/03/2025$2.94$3.00
+2.04%
$3.10$2.9228,240 shs$6.70 million
01/02/2025$3.05$2.94
-3.61%
$3.05$2.8026,348 shs$6.57 million
01/01/2025$3.05$3.05$3.16$3.0550,624 shs$6.81 million
12/31/2024$3.05$3.05$3.16$3.0550,624 shs$6.81 million
12/30/2024$3.02$3.05
+0.99%
$3.20$2.6177,447 shs$6.81 million
12/27/2024$3.09$3.02
-2.27%
$3.14$2.8089,256 shs$6.75 million
12/26/2024$3.20$3.09
-3.44%
$3.20$2.82291,075 shs$6.90 million
12/25/2024$3.20$3.20$3.39$2.72651,001 shs$7.15 million
12/24/2024$2.81$3.20
+13.88%
$3.39$2.72651,001 shs$7.15 million
12/23/2024$1.75$2.81
+61.03%
$4.10$2.4220.81 million shs$6.28 million
12/20/2024$1.92$1.75
-9.11%
$2.09$1.7286,166 shs$3.90 million


This page (NASDAQ:GTBP) was last updated on 1/21/2025 by MarketBeat.com Staff
From Our Partners